Article
Economic Burden of Sanfilippo Syndrome in the United States
2023-11-01
Abstract excerpt
<title>Abstract</title> <p> <bold>Introduction:</bold> Sanfilippo syndrome is a rare disease and fatal genetic disorder with no FDA-approved treatment in the United States (US), and no comprehensive assessment of economic disease burden is available. <bold>Objectives:</bold> To develop a model to estimate the economic burden associated with Sanfilippo syndrome in the US using direct costs, indirect costs and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d8c94f0-cb75-55b3-acc1-71f53e4f973f
- DOI
- 10.21203/rs.3.rs-3001450/v4
